News – Page 426 – Endpoints News

FDA rejects Crinetics' current PhII design for hyperinsulinism drug

3 years ago

Mirum discontinues PhIIb 'Ohana' study in pregnancy setting

3 years ago

Lundbeck-partnered preclinical biotech nabs Series A from AstraZeneca

3 years ago

New TIGIT data cut from Gilead, Arcus sets the stage for full readout

3 years ago

Cajal Neuroscience launches with $96M Series A, tackling Alzheimer's and Parkinson's

3 years ago

Updated: Roche pulls PD-L1 blockbuster's accelerated approval in bladder cancer

3 years ago

With ops spanning Belgium and China, Full-Life inks $245M buyout to beef up radiopharma pipeline

3 years ago

Updated: AstraZeneca jumps deeper into cell therapy 2.0 space with $320M biotech M&A

3 years ago

Sanofi welcomes 500 staffers to new Paris HQ after €30M renovation

3 years ago

Stada to place $50M+ investment in a new facility in Romania

3 years ago

US seeks jail time for co-CEO of New England compounding center after deadly 2012 fungal outbreak

3 years ago

Pfizer CEO under fire from UK watchdog over vaccine comments — report

3 years ago

FDA tells Catalent to fix issues at two manufacturing sites on its own

3 years ago

Post-Brexit UK trade report shows 'worrying' signs for life sciences

3 years ago

Merck's latest 'Why Vaccines' campaign seeks to better inform vaccine-hesitant moms

3 years ago

Industry groups, CVS pick apart FDA's proposed pathway for generics to carve out OTC indications

3 years ago

Fourth accelerated approval in Duchenne? Sarepta gets priority review for gene therapy amid FDA scrutiny

3 years ago

San Diego biotech lands $120M to launch a slate of trials in neurosensory disorders

3 years ago

Nearly a year after his SPAC combines with EQRx, Eli Casdin resigns from board

3 years ago

CinCor’s hypertension candidate flops a PhII test but plans to charge ahead with pivotal study

3 years ago

Axsome's approved depression drug clears Alzheimer's agitation trial months after Lundbeck-Otsuka duo

3 years ago

Lilly joins in expanded Series A round for BeiGene-partnered mRNA biotech

3 years ago

In new deal, AstraZeneca places small bet on 'critical but challenging' target

3 years ago

Vaccine documents, young leaders and market turmoil: Endpoints' 10 biggest stories of 2022

3 years ago

First page Previous page 423 424 425426427 428 429 Next page Last page